Dr. Wolpin is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
450 Brookine Ave, D1220
Dana Farber Cancer Institute
Boston, MA 02215Phone+1 617-632-6942Fax+1 617-632-5370
Education & Training
Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 2004 - 2006- Brigham and Women's HospitalResidency, Internal Medicine, 2001 - 2004
Harvard Medical SchoolClass of 2001
Certifications & Licensure
MA State Medical License 2003 - 2026
NH State Medical License 2024 - 2026- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Panitumumab in Cetuximab Refractory KRAS Wild-Type Colorectal Cancer Start of enrollment: 2009 May 01
- RAD001 and AV-951 in Patients With Refractory, Metastatic Colorectal Cancer Start of enrollment: 2010 Feb 01
- Hydroxychloroquine in Previously Treated Patients With Metastatic Pancreatic Cancer Start of enrollment: 2011 Jan 01
- Join now to see all
Publications & Presentations
PubMed
- Early detection of pancreatic cancer: Study design and analytical considerations in biomarker discovery and early phase validation studies.Lynette M Smith, Douglas W Mahoney, William R Bamlet, Fang Yu, Suyu Liu
Pancreatology. 2024-12-01 - Author Correction: Tumour-selective activity of RAS-GTP inhibition in pancreatic cancer.Urszula N Wasko, Jingjing Jiang, Tanner C Dalton, Alvaro Curiel-Garcia, A Cole Edwards
Nature. 2024-11-01 - 10 citationsMechanisms of Resistance to Oncogenic KRAS Inhibition in Pancreatic Cancer.Julien Dilly, Megan T Hoffman, Laleh Abbassi, Ziyue Li, Francesca Paradiso
Cancer Discovery. 2024-11-01
Journal Articles
- Diabetes, Weight Change, and Pancreatic Cancer RiskDouglas A Rubinson, Kimmie Ng, Meir J Stampfer, Brian M Wolpin, JAMA Oncology
- Germline Cancer Susceptibility Gene Variants, Somatic Second Hits, and Survival Outcomes in Patients with Resected Pancreatic CancerRichard F Dunne, Leona A Doyle, William C Hahn, Jason L Hornick, Andrea J Bullock, Sapna Syngal, Albert C Koong, Natalia Khalaf, Brian M Wolpin, Douglas A Rubinson, Da..., Nature
- Altered Exocrine Function Can Drive Adipose Wasting in Early Pancreatic CancerJared R Mayers, Naoki Takahashi, Nicole Lopez, Brian M Wolpin, Nature
Authored Content
- Diabetes, Weight Change, and Pancreatic Cancer RiskAugust 2020
- Diabetes, Weight Change, and Pancreatic Cancer RiskAugust 2020
- Diabetes, Weight Change, and Pancreatic Cancer RiskAugust 2020
- Diabetes, Weight Change, and Pancreatic Cancer RiskAugust 2020
- Diabetes, Weight Change, and Pancreatic Cancer RiskAugust 2020
- Join now to see all
Press Mentions
Don't Ignore These Pancreatic Cancer Warning SignsApril 28th, 2023- Novobiocin Attacks BRCA-Mutated Cancer Cells from Within and Without, Study ShowsMarch 14th, 2023
- Looking for Early Warning Signs of Pancreatic CancerMarch 22nd, 2022
- Join now to see all
Grant Support
- Cohort Study Of Biochemical And Genetic Risk Factors For Pancreatic CancerNational Cancer Institute2009–2011
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
